• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌微环境的回顾性研究:利用公开的单细胞RNA测序数据集分析肿瘤相关成分的新型标志物、相互作用及机制

A Retrospective View of the Triple-Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components Using Public Single-Cell RNA-Seq Datasets.

作者信息

Kim Minsoo, Yang Wonhee, Hong Dawon, Won Hye Sung, Yoon Seokhyun

机构信息

Department of Computer Science, College of SW Convergence, Dankook University, Yongin 16890, Republic of Korea.

Department of AI-Based Convergence, College of SW Convergence, Dankook University, Yongin 16890, Republic of Korea.

出版信息

Cancers (Basel). 2024 Mar 16;16(6):1173. doi: 10.3390/cancers16061173.

DOI:10.3390/cancers16061173
PMID:38539508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10969223/
Abstract

Triple-negative breast cancer (TNBC) is a significant clinical challenge due to its aggressive nature and limited treatment options. In search of new treatment targets, not only single genes but also gene pairs involved in protein interactions, we explored the tumor microenvironment (TME) of TNBC from a retrospective point of view, using public single-cell RNA sequencing datasets. A High-resolution Cell type Annotation Tool, HiCAT, was used first to identify the cell type in 3-level taxonomies. Tumor cells were then identified based on the estimates of copy number variation. With the annotation results, differentially expressed genes were analyzed to find subtype-specific markers for each cell type, including tumor cells, fibroblast, and macrophage. Cell-cell interactions were also inferred for each cell type pair. Through integrative analysis, we could find unique TNBC markers not only for tumor cells but also for various TME components, including fibroblasts and macrophages. Specifically, twelve marker genes, including and , were identified for TNBC tumor cells. Another key finding of our study was the interaction between the and genes among TNBC tumor cells, suggesting that they are more tightly aggregated with each other than those of other subtypes, including normal epithelial cells. The overexpression of in TNBC and its prognostic power were verified by using METABRIC, a large bulk RNA-seq dataset with clinical information. These findings not only corroborate previous hypotheses but also lay the foundation for a new structural understanding of TNBC, as revealed through our single-cell analysis workflow.

摘要

三阴性乳腺癌(TNBC)因其侵袭性本质和有限的治疗选择而成为一项重大的临床挑战。为了寻找新的治疗靶点,我们不仅关注单个基因,还关注参与蛋白质相互作用的基因对,利用公开的单细胞RNA测序数据集,从回顾性角度探索了TNBC的肿瘤微环境(TME)。首先使用一种高分辨率细胞类型注释工具HiCAT在三级分类法中识别细胞类型。然后根据拷贝数变异估计来识别肿瘤细胞。根据注释结果,分析差异表达基因以找到每种细胞类型(包括肿瘤细胞、成纤维细胞和巨噬细胞)的亚型特异性标志物。还推断了每种细胞类型对之间的细胞-细胞相互作用。通过综合分析,我们不仅可以找到TNBC肿瘤细胞的独特标志物,还可以找到包括成纤维细胞和巨噬细胞在内的各种TME成分的独特标志物。具体而言,为TNBC肿瘤细胞鉴定了12个标志物基因,包括[具体基因1]和[具体基因2]。我们研究的另一个关键发现是TNBC肿瘤细胞中[基因3]和[基因4]之间的相互作用,这表明它们彼此之间的聚集比其他亚型(包括正常上皮细胞)更为紧密。通过使用METABRIC(一个带有临床信息的大型批量RNA测序数据集)验证了[基因5]在TNBC中的过表达及其预后能力。这些发现不仅证实了先前的假设,还为通过我们的单细胞分析工作流程揭示的TNBC的新结构理解奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/e327104fee71/cancers-16-01173-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/825b5aea4d05/cancers-16-01173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/3e7e114011f0/cancers-16-01173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/979c9cc9b693/cancers-16-01173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/048f241f91bf/cancers-16-01173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/a8798ff0ece5/cancers-16-01173-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/a0f541a371ec/cancers-16-01173-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/e327104fee71/cancers-16-01173-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/825b5aea4d05/cancers-16-01173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/3e7e114011f0/cancers-16-01173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/979c9cc9b693/cancers-16-01173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/048f241f91bf/cancers-16-01173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/a8798ff0ece5/cancers-16-01173-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/a0f541a371ec/cancers-16-01173-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc98/10969223/e327104fee71/cancers-16-01173-g007.jpg

相似文献

1
A Retrospective View of the Triple-Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components Using Public Single-Cell RNA-Seq Datasets.三阴性乳腺癌微环境的回顾性研究:利用公开的单细胞RNA测序数据集分析肿瘤相关成分的新型标志物、相互作用及机制
Cancers (Basel). 2024 Mar 16;16(6):1173. doi: 10.3390/cancers16061173.
2
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.单细胞RNA测序和批量RNA测序的综合分析揭示了三阴性乳腺癌中与T细胞相关的预后风险模型及肿瘤免疫微环境调节。
Comput Biol Med. 2023 Jul;161:107066. doi: 10.1016/j.compbiomed.2023.107066. Epub 2023 May 27.
3
Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.鉴定 DDIT4 作为三阴性乳腺癌化疗和免疫治疗反应相关的潜在预后标志物。
World J Surg Oncol. 2023 Jun 30;21(1):194. doi: 10.1186/s12957-023-03078-7.
4
Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer.解析三阴性乳腺癌肿瘤细胞和微环境的异质性及其临床意义
Front Oncol. 2021 Mar 29;11:557477. doi: 10.3389/fonc.2021.557477. eCollection 2021.
5
Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.肿瘤微环境中三阴性乳腺癌(TNBC)中 Toll 样受体表达的全景:TLR4 和 TLR8 的不同作用。
Gene. 2021 Aug 5;792:145728. doi: 10.1016/j.gene.2021.145728. Epub 2021 May 20.
6
Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.调节性 T 细胞与三阴性乳腺癌的肿瘤免疫微环境和免疫治疗反应有关。
Front Immunol. 2023 Sep 12;14:1263537. doi: 10.3389/fimmu.2023.1263537. eCollection 2023.
7
The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs.三阴性乳腺癌的分子亚型被定义,并通过对配体-受体对的综合分析构建了配体-受体对评分模型。
Front Immunol. 2022 Aug 31;13:982486. doi: 10.3389/fimmu.2022.982486. eCollection 2022.
8
CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer.CDKN2A 介导的分子亚型可作为肿瘤微环境的特征,并指导三阴性乳腺癌的精准医学。
Front Immunol. 2022 Aug 16;13:970950. doi: 10.3389/fimmu.2022.970950. eCollection 2022.
9
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer.癌症相关成纤维细胞图谱鉴定出分泌型双糖链蛋白聚糖是三阴性乳腺癌中的一种促肿瘤和免疫抑制因子。
Oncoimmunology. 2022 Jan 3;11(1):2020984. doi: 10.1080/2162402X.2021.2020984. eCollection 2022.
10
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting.肿瘤微环境与三阴性乳腺癌的侵袭性:揭示机制与靶向治疗。
Expert Opin Ther Targets. 2022 Dec;26(12):1041-1056. doi: 10.1080/14728222.2022.2170779. Epub 2023 Jan 29.

引用本文的文献

1
Predictive value of tumoral and peritumoral radiomic features in neoadjuvant chemotherapy response for breast cancer: a retrospective study.肿瘤及瘤周影像组学特征对乳腺癌新辅助化疗反应的预测价值:一项回顾性研究
Radiol Med. 2025 Feb 24. doi: 10.1007/s11547-025-01969-1.

本文引用的文献

1
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC.单细胞 RNA-seq 和 bulk RNA-seq 的综合分析揭示了三阴性乳腺癌中癌症相关成纤维细胞的异质性。
Aging (Albany NY). 2023 Nov 13;15(21):12674-12697. doi: 10.18632/aging.205205.
2
Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms.鉴定与乳腺癌生存和风险相关的基因表达特征,该特征可改善临床基因组平台。
Bioinform Adv. 2023 Mar 22;3(1):vbad037. doi: 10.1093/bioadv/vbad037. eCollection 2023.
3
The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients.
桥粒蛋白桥粒芯胶蛋白2在三阴性乳腺癌患者肿瘤进展中的作用。
Cancer Cell Int. 2023 Mar 16;23(1):47. doi: 10.1186/s12935-023-02896-9.
4
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment.乳腺癌各亚型中的肿瘤浸润淋巴细胞:生物标志物评估的当前问题
Cancers (Basel). 2023 Jan 26;15(3):767. doi: 10.3390/cancers15030767.
5
Hierarchical cell-type identifier accurately distinguishes immune-cell subtypes enabling precise profiling of tissue microenvironment with single-cell RNA-sequencing.层次化细胞类型标识符能够准确地区分免疫细胞亚型,从而能够通过单细胞 RNA 测序对组织微环境进行精确分析。
Brief Bioinform. 2023 Mar 19;24(2). doi: 10.1093/bib/bbad006.
6
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.分析乳腺癌亚型间肿瘤微环境异质性,鉴定亚型特异性特征。
Genes (Basel). 2022 Dec 23;14(1):44. doi: 10.3390/genes14010044.
7
GSEApy: a comprehensive package for performing gene set enrichment analysis in Python.GSEApy:一个用于在 Python 中进行基因集富集分析的综合软件包。
Bioinformatics. 2023 Jan 1;39(1). doi: 10.1093/bioinformatics/btac757.
8
Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer.细胞间通讯揭示了上皮-间质转化在三阴性乳腺癌治疗中的潜力。
Biomolecules. 2022 Oct 14;12(10):1478. doi: 10.3390/biom12101478.
9
Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers.钙调蛋白在癌症中的新作用:结直肠癌及其他癌症的潜在生物标志物
World J Gastrointest Oncol. 2022 Sep 15;14(9):1637-1653. doi: 10.4251/wjgo.v14.i9.1637.
10
CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer.CDKN2A 介导的分子亚型可作为肿瘤微环境的特征,并指导三阴性乳腺癌的精准医学。
Front Immunol. 2022 Aug 16;13:970950. doi: 10.3389/fimmu.2022.970950. eCollection 2022.